Hidehito Horinouchi
- Oncology top 1%
- Lung Cancer Research Studies 64
- Cancer Immunotherapy and Biomarkers 61
- Colorectal Cancer Treatments and Studies 38
- HER2/EGFR in Cancer Research 14
-
- Lung Cancer Treatments and Mutations 145
- Lung Cancer Diagnosis and Treatment 52
- Neurology top 5%
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 19
- Clinical Biochemistry top 5%
-
- Neuroendocrine Tumor Research Advances 20
- Co-authors
- Yuichiro OheNoboru YamamotoShintaro KandaYutaka FujiwaraHiroshi NokiharaYasushi GotoTomohide TamuraKoji Tsuta
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hidehito Horinouchi
202 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 108
- Oncology 2.0k
- Pulmonary and Respiratory Medicine 1.7k
- Neurology 359
- Cancer Research 309
- Clinical Biochemistry 104
Countries citing papers authored by Hidehito Horinouchi
This map shows the geographic impact of Hidehito Horinouchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidehito Horinouchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidehito Horinouchi more than expected).
Fields of papers citing papers by Hidehito Horinouchi
This network shows the impact of papers produced by Hidehito Horinouchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidehito Horinouchi. The network helps show where Hidehito Horinouchi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hidehito Horinouchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 21 | |
| 12 | 2022 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 18 | |
| 15 | 2021 | 10 | |
| 16 | 2020 | 15 | |
| 17 | 2020 | 36 | |
| 18 | 2018 | 10 | |
| 19 | 2018 | 5 | |
| 20 | 2018 | 58 |
About Hidehito Horinouchi
Hidehito Horinouchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 225 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (145 papers), Lung Cancer Research Studies (64 papers), Cancer Immunotherapy and Biomarkers (61 papers), Lung Cancer Diagnosis and Treatment (52 papers), Colorectal Cancer Treatments and Studies (38 papers), Neuroendocrine Tumor Research Advances (20 papers), Cancer Genomics and Diagnostics (19 papers) and HER2/EGFR in Cancer Research (14 papers). The work is most often cited by research in Oncology (2.0k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Neurology (359 citations). Hidehito Horinouchi has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yuichiro Ohe, Noboru Yamamoto, Shintaro Kanda, Yutaka Fujiwara, Hiroshi Nokihara, Yasushi Goto, Tomohide Tamura, Koji Tsuta, Yuji Matsumoto and Shun‐ichi Watanabe. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.